Nestlé To Develop Products For Users Of 'Miracle' Weight-Loss Drugs Like Ozempic, Wegovy
Portfolio Pulse from Benzinga Neuro
Nestlé SA (OTC:NSRGY) plans to develop products that pair with popular weight-loss medications like Ozempic, Wegovy, and Mounjaro. The move comes amid concerns about the potential impacts these appetite-suppressing drugs might have on the food industry. Nestlé's CEO, Mark Schneider, stated that the company's portfolio will not be significantly affected as consumers will continue to consume coffee and pet food, two of the company’s major revenue streams.
October 20, 2023 | 9:39 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Nestlé's move to develop products that pair with weight-loss medications could potentially open a new revenue stream for the company. However, the impact on the company's stock is uncertain.
Nestlé's move to develop products that pair with weight-loss medications could potentially open a new revenue stream for the company. However, the impact on the company's stock is uncertain as it depends on the success of these new products and their acceptance in the market.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100